Small-cap stocks may have outperformed their mid- and larger-cap peers on a year-over-year basis, yet opportunities within the sector can often go overlooked by investors for bigger-name plays; observes Karee Venema of Schaeffer Investment Research.
One equity that falls under the small-cap umbrella, and looks poised to benefit from a contrarian boon is shipping concern Frontline Ltd. (FRO).
Shares of Frontline have more than doubled in value since hitting a decade-plus low of $1.71 last May. In fact, the stock tagged a new annual high of $5.18 in early January.
The equity entered a brief period of consolidation after notching this notable mark, but the pullback was contained by its 50-day moving average�� trendline that served as support last September.
Not everyone on the Street has bought into FRO's momentum, though, which could translate into a contrarian boost down the road.
For starters, not one of the five covering analysts deems the stock worthy of a "buy" or better rating. Plus, the average 12-month price target of $1.78 stands at a steep discount to the equity's current perch.
Top 5 Dow Dividend Stocks To Invest In Right Now: LCY Chemical Corp (1704.TW)
LCY Chemical Corporation is principally engaged in the manufacture and distribution of polypropylene (PP), solvents and other chemical products. The Company provides methanol products, including methanol, formaldehyde, paraformaldehyde and dimethyl ether, among others; solvents, including ethyl acetate, isopropyl alcohol and methyl isobutyl ketone, as well as electronic chemical products, PP related products, thermoplastic rubber and liquefied petroleum gas (LPG). Its products are applied in the manufacture of resins, agricultural pesticides, catalysts, medicines, paintings, inks, artificial leather products, shoes, industrial products, electronic components, toys and electrical appliances, among others. On June 23, 2014, it acquired a certain shares of TECHNOLOGY CORP. After that, it holds 86.65% stake of LCY TECHNOLOGY CORP. Advisors' Opinion:- [By Anna Prior]
Kraton Performance Polymers Inc.'s(KRA) board is no longer pushing for the company’s stockholders to approve its plans to combine with LCY Chemical Corp.'s(1704.TW) styrenic block copolymer operations.
5 Best Gas Utility Stocks To Watch For 2014: Makism 3D Corp (MDDD)
Makism 3D Corp., incorporated on May 4 2010, is a three dimensional (3D) printer manufacturing company. The Company produces consumer and professional grade 3D printers. The Company�� flagship product, branded as the Wideboy family of printers, offers packaging designed to fit any office or professional space.
Its 3D printers utilize British and German engineered components. Its printers are assembled in Cambridge (United Kingdom).
Advisors' Opinion:- [By James E. Brumley]
In retrospect, their pullbacks come as no real surprise. Neither Voxeljet AG (NYSE:VJET) nor Camtek LTD. (NASDAQ:CAMT) saw their shares soar on any news that was meaningfully sustainable, and after the "shoot first, ask questions later" market had a chance to start asking questions, it became clear that - even with the largest of glimmers of corporate progress unveiled a few weeks ago - CAMT and VJET both had been bid up more on hype and less on substance. Meanwhile (and this could be bitterly ironic to some), a small cap play in the same 3D printing space that (1) didn't beat the daylights out of its hype-drum, and (2) is actually much closer to bringing a revenue-bearing product to the market [per today's news - more on that below] isn't getting anywhere near the same attention. That company? Makism 3D Corp. (OTCBB:MDDD). The good news is, MDDD finally looks like it's revving its engine, while Camtek and Voxeljet AG shares continue to deteriorate.
- [By John Udovich]
Although the subject of a recent market correction,�3D printing and 3D printer stocks like�3D Systems Corporation (NYSE: DDD), Stratasys, Ltd. (NASDAQ: SSYS), ExOne Co (NASDAQ: XONE)�and Makism 3D Corp. (OTCBB: MDDD) largely remain hot, but what strategy should investors and/or traders alike take moving forward? Just consider the following latest news about the 3D printing industry or�3D printer stocks:
- [By James E. Brumley]
They say the great ones withstand the test of time. If that's true of stocks (and it is), then it's becoming increasingly safer to say Makism 3D Corp. (OTCMKTS:MDDD) is one of the great ones within the 3D printing world. No, it's neither as big nor as prolific as 3D printer names like 3D Systems Corporation (NYSE:DDD) or Stratasys, Ltd. (NASDAQ:SSYS). Then again, everything is relative; MDDD may well be packing more of a punch for its investors than SSYS or DDD have in a long time.
5 Best Gas Utility Stocks To Watch For 2014: Great Northern Iron Ore Properties (GNI)
Great Northern Iron Ore Properties, a conventional nonvoting trust, owns and leases mineral and non-mineral properties on the Mesabi Iron Range in northeastern Minnesota. It owns mineral interests on the Mesabi Iron Range formation that represent 12,033 acres, including approximately 9,895 acres are under lease and 2,138 acres are unleased. The company was founded in 1906 and is based in Saint Paul, Minnesota.
Advisors' Opinion:- [By Aaron Levitt]
PrairieSky won�� actually be drilling for oil or natural gas on its properties, nor will it be transporting it through pipelines. That’s because a�royalty trust is an entity�that own the production rights on oil wells, natural gas fields or, as in the case of Great Northern Iron Ore Properties (GNI),�iron ore mines.
5 Best Gas Utility Stocks To Watch For 2014: Medidata Solutions Inc.(MDSO)
Medidata Solutions, Inc. provides software-as-a-service based clinical development solutions for life science organizations worldwide. Its solutions comprise software and services that allow customers to increase the value of their development programs by designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. The company primarily offers Medidata Rave, a comprehensive platform for capturing and managing clinical data. It also provides Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, a protocol development tool that enhances the efficiency of clinical trial start-up; Medidata Insights, a busi ness analytics platform; and Medidata Balance, a randomization and trial supply management solution, which streamlines the process of developing, building, and implementing subject allocation plans. In addition, the company offers Medidata Grants Manager, an application to benchmark the investigator budgets against industry data; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and iMedidata, a hosted portal application that allows investigative sites and sponsor study teams to start trial activities. Further, it provides hosting, support, and professional services. The company serves pharmaceutical, biotechnology, and medical device companies; academic institutions; and CROs and other entities engaged in clinical trials through a direct sales force; and through relationships with CROs and other strategic partners. The company was founded in 1999 and is headquartered in New York, New York.
Advisors' Opinion:- [By Jonas Elmerraji]
Mid-cap medical software stock Medidata Solutions (MDSO) is the smallest name on today's list by far, but it's hard to ignore the technical trade that's been setting up in shares. Even though MDSO has already rallied more than 52% since the start of 2013, this name looks well positioned for some serious continuation in the New Year.
That's because Medidata is currently forming an ascending triangle pattern, a bullish price setup that's formed by overhead resistance at $62.50 and uptrending support to the downside. Basically, as shares bounce in between those two technical price levels, they're getting squeezed closer and closer to a breakout above resistance. When that move through $62.50 happens, we've got our buy signal.
MDSO is another name that's been showing off outsized relative strength lately. Considering the fact that the S&P look likely to show us a healthy correction sooner rather than later, positive relative strength trends are the single most important technical indicator traders can ask for right now. When the buy signal comes, I'd recommend putting a stop on the other side of the 50-day moving average.
Berkshire Hathaway (BRK.A)Berkshire Hathaway, on the other hand, hasn't been seeing much in the way of relative strength in the last few months. Since the start of July, Berkshire's shares have only managed to gain a third of what the broad market has returned. But a breakout in shares of Warren Buffett's favorite stock means that fortunes are likely about to turn for shareholders.
Berkshire had been forming symmetrical triangle, a pattern that's formed by converging trendlines squeezing in on the stock's price at a nearly even rate. The symmetrical triangle has less upside bias than the ascending triangle we just looked at, but the trading trigger is essentially the same -- a breakout outside of the pattern is the signal to make a move. So, shares of Berkshire are flashing "buy" now.
With the brea
- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Medidata Solutions (NASDAQ: MDSO) were 27.49 percent to $38.21 after the company reported downbeat quarterly results. - [By Kevin Marder]
Among the names, Medidata Solutions (MDSO) is a developer of clinical development software for use in the research of new medical treatments. Most Wall Street analysts forecast earnings growth of 38% in 2013 and 13% in 2014. Revenue growth over the past several quarters has been very steady, at 21%, 24%, 26%, 27% and 27%, respectively.
- [By Ben Levisohn]
The iShares Russell 2000 ETF (IWM) has dropped 5.2% so far this year, while Mueller Industries (MLI), which has plunged 55%, Medidata Solutions (MDSO), which has plummeted 44%, Financial Engines (FNGN), which has slid 42%, and Isis Pharmaceuticals (ISIS), which has tumbled 42%, are the index’s biggest losers.
No comments:
Post a Comment